Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Smartphone app hits Europe for Abbott’s continuous glucose monitor

Abbott announced Feb. 7 the FreeStyle LibreLink smartphone application—to be used alongside the company’s continuous glucose monitor—is now available to iPhone and Android users in 12 European countries.

Many OHCA patients don’t benefit from immediate coronary treatment

A simple tool to predict neurological outcomes for sufferers of out-of-hospital cardiac arrest (OHCA) could help clinicians determine when invasive coronary management is futile, a study in JACC: Cardiovascular Interventions suggests.

ICDs linked to more hospitalizations for patients with heart failure, CKD

For nearly 6,000 patients with heart failure and chronic kidney disease (CKD), the use of an implantable cardioverter defibrillator (ICD) showed no mortality benefit but a higher risk of subsequent hospitalizations after covariate adjustment, researchers reported in JAMA Internal Medicine.

Thumbnail

In-clinic readings miss 56% of hypertension cases in severely preeclamptic women

Hypertension during pregnancy is far from a rarity, but in women with severe preeclampsia, the diagnosis could be both cloaked and fatal, new research published in Hypertension suggests.

Thumbnail

Heart & hearing: Noise pollution tied to higher risk of stroke, MI

Exposure to noise pollution has been shown to negatively impact cardiovascular health. But researchers have only recently begun to explore exactly how noise can harm health. A study published online Feb. 6 in the Journal of the American College of Cardiology explored the connection between noise and arterial hypertension, myocardial infarction, heart failure and stroke.

Secondary prevention is poor following revascularization—particularly for CABG

Compliance with guideline-directed medical therapy (GDMT) is low following coronary revascularization—but especially low after coronary artery bypass grafting (CABG), possibly influencing the common comparisons between CABG and percutaneous coronary intervention (PCI).

Aspirin deemed worthless for heart failure patients without AFib

Aspirin is ineffective in preventing heart attack, stroke and death in heart failure patients without atrial fibrillation (AFib), according to a nationwide study in Denmark. In fact, patients on aspirin may be more likely to have myocardial infarction (MI) or be rehospitalized for heart failure, Christian Madelaire, MD, and colleagues reported in JACC: Heart Failure.

Thumbnail

Long-term study supports CABG over PCI in young patients with severe CAD

Younger patients with three-vessel coronary artery disease benefit more from coronary artery bypass grafting (CABG) than percutaneous coronary intervention (PCI) in the long run, suggests a study presented Jan. 30 at the Society of Thoracic Surgeons’ annual meeting in Fort Lauderdale, Florida.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.